Molecular Mechanisms of Alzheimer’s Disease Protection by the A673T Allele of Amyloid Precursor Protein

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Variant of TREM2 associated with the risk of Alzheimer's disease.

  2013cited by this paper
• TREM2 variants in Alzheimer's disease.

  2013cited by this paper
• The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes

  2012cited by this paper
• A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

  2012influential reference
• Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families

  2012cited by this paper
• Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance

  2011cited by this paper
• Preparing synthetic Aβ in different aggregation states.

  2011cited by this paper
• The role of microglia in amyloid clearance from the AD brain

  2010cited by this paper
• A Recessive Mutation in the APP Gene with Dominant-Negative Effect on Amyloidogenesis

  2009influential reference
• APP binds DR6 to trigger axon pruning and neuron death via distinct caspases

  2009cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• Extreme cerebrospinal fluid amyloid β levels identify family with late‐onset Alzheimer's disease presenilin 1 mutation

  2007cited by this paper
• The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation

  2001cited by this paper
• Presenilin mutations line up along transmembrane alpha-helices.

  2001cited by this paper
• Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability.

  2001cited by this paper
• Differences in the Abeta40/Abeta42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype.

  2000cited by this paper
• Novel Leu723Pro amyloid precursor protein mutation increases amyloid β42(43) peptide levels and induces apoptosis

  2000cited by this paper
• Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease.

  1998cited by this paper
• Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease.

  1996cited by this paper
• An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

  1994cited by this paper
• Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.

  1992cited by this paper
• Codon 618 variant of alzheimer amyloid gene associated with inherited cerebral hemorrhage

  1991cited by this paper
• Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type.

  1990cited by this paper
• Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch).

  1990cited by this paper

• Isogenic cortical organoids enable precision targeting of APP variant-specific pathways in Alzheimer’s disease

  2026cites this paper
• HOPS disruption impairs APP trafficking and processing, promoting exosomal secretion of APP-CTFs.

  2026cites this paper
• The Icelandic mutation APPA673T on amyloid-β plaque burden in the 5xFAD Alzheimer model

  2025cites this paper
• The impact of rare genetic variants on Alzheimer disease

  2025cites this paper
• Evaluating pathogenicity of variants of unknown significance in APP, PSEN1, and PSEN2

  2025cites this paper
• Amyloid Precursor Protein (APP) A673T Mutation as a Model for Developing Preventive Strategies in Alzheimer’s Disease

  2025cites this paper
• BACE Inhibitor Clinical Trials for Alzheimer’s Disease

  2024cites this paper
• Long term rescue of Alzheimer’s deficits in vivo by one-time gene-editing of App C-terminus

  2024cites this paper
• Associations of CSF BACE1 with amyloid pathology, neurodegeneration, and cognition in Alzheimer’s disease

  2024cites this paper
• The AβA2V Paradigm: From Molecular Insights to Therapeutic Strategies in Alzheimer's disease and primary tauopathies.

  2024cites this paper
• Evaluation of hydrazone and N-acylhydrazone derivatives of vitamin B6 and pyridine-4-carbaldehyde as potential drugs against Alzheimer’s disease

  2024cites this paper
• Transmissible long-term neuroprotective and pro-cognitive effects of 1–42 beta-amyloid with A2T icelandic mutation in an Alzheimer’s disease mouse model

  2024cites this paper
• Preliminary In Vitro and In Vivo Insights of In Silico Candidate Repurposed Drugs for Alzheimer’s Disease

  2023cites this paper
• Experimental approaches for altering the expression of Abeta‐degrading enzymes

  2023cites this paper
• Protective Alzheimer ’ s disease-associated APP A673T variant predominantly decreases sAPP β levels in cerebrospinal fluid and 2D/3D cell culture models

  2023cites this paper
• An Alternative View of Familial Alzheimer’s Disease Genetics

  2023cites this paper
• Aβ1-6A2V(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury

  2023cites this paper
• Protective Alzheimer's disease-associated APP A673T variant predominantly decreases sAPPβ levels in cerebrospinal fluid and 2D/3D cell culture models.

  2023cites this paper
• AAV‐mediated delivery of an anti‐BACE1 VHH alleviates pathology in an Alzheimer's disease model

  2022cites this paper
• Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids

  2022cites this paper
• Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer’s disease brain extracts

  2022cites this paper
• A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease

  2022cites this paper
• An insight into the iPSCs-derived two-dimensional culture and three-dimensional organoid models for neurodegenerative disorders

  2022cites this paper
• Exploring the Involvement of the Amyloid Precursor Protein A673T Mutation against Amyloid Pathology and Alzheimer’s Disease in Relation to Therapeutic Editing Tools

  2022influential citation
• Alzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint

  2022cites this paper
• Unraveling pathological mechanisms in neurological disorders: the impact of cell-based and organoid models

  2022cites this paper
• Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD in vitro

  2021cites this paper
• The case for low-level BACE1 inhibition for the prevention of Alzheimer disease

  2021cites this paper
• The Amyloid-β Pathway in Alzheimer’s Disease

  2021cites this paper
• The Uppsala APP deletion causes early onset autosomal dominant Alzheimer’s disease by altering APP processing and increasing amyloid β fibril formation

  2021cites this paper
• Nutraceutical and Probiotic Approaches to Examine Molecular Interactions of the Amyloid Precursor Protein APP in Drosophila Models of Alzheimer’s Disease

  2021cites this paper
• Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions

  2021cites this paper
• The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer’s Disease

  2021influential citation
• Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes

  2021cites this paper
• Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?

  2021cites this paper
• Gene therapy using Aβ variants for amyloid reduction.

  2021cites this paper
• Stem Cell Therapies in Alzheimer’s Disease: Applications for Disease Modeling

  2021cites this paper
• Post-Translational Modifications of BACE1 in Alzheimer's Disease

  2021cites this paper
• Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2

  2020cites this paper
• Aggregation Mechanism of Alzheimer’s Amyloid β-Peptide Mediated by α-Strand/α-Sheet Structure

  2020cites this paper
• Opposite changes in APP processing and human Aβ levels in rats carrying either a protective or a pathogenic APP mutation

  2020cites this paper
• Compact fibril-like structure of amyloid β-peptide (1-42) monomers.

  2020cites this paper
• The protective mutation A673T in amyloid precursor protein gene decreases Aβ peptides production for 14 forms of Familial Alzheimer’s Disease in SH-SY5Y cells

  2020cites this paper
• The Role of APP O-Glycosylation in Alzheimer’s Disease

  2020cites this paper
• Base editing strategy allows insertion of the A673T mutation in APP gene to prevent the development of Alzheimer’s disease

  2020cites this paper
• Alzheimer’s protection effect of A673T mutation may be driven by lower Aβ oligomer binding affinity

  2020influential citation
• Generation of a human induced pluripotent stem cell line (UEFi003-A) carrying heterozygous A673T variant in amyloid precursor protein associated with a reduced risk of Alzheimer's disease.

  2020cites this paper
• Passive immunotherapies targeting Aβ and tau in Alzheimer's disease

  2020cites this paper
• The Links between Cardiovascular Diseases and Alzheimer's Disease

  2020cites this paper
• New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AβPP-β Cleavage Decreasing Amyloid-β Production and Accumulation in Alzheimer’s Disease Models

  2020cites this paper
• Mechanisms of neurodegeneration - Insights from familial Alzheimer's disease.

  2020cites this paper
• Is It the Twilight of BACE1 Inhibitors?

  2020cites this paper
• CERAMIDE-ENRICHED EXTRACELLULAR VESICLES: A ROLE IN ENHANCING AMYLOID-BETA NEUROTOXICITY AND MITOCHONDRIAL DAMAGE IN ALZHEIMER’S DISEASE

  2020cites this paper
• Genetic Editing and Pharmacogenetics in Current And Future Therapy Of Neurocognitive Disorders.

  2020cites this paper
• Real-time nanoscale organization of amyloid precursor protein.

  2020cites this paper
• Molecular dynamics simulations of copper binding to N-terminus mutants of amyloid-β

  2020cites this paper
• Galectin 3–binding protein suppresses amyloid-β production by modulating β-cleavage of amyloid precursor protein

  2020cites this paper
• The Alzheimer’s Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease

  2020cites this paper
• The Role of Genetics in Alzheimer's Disease and Parkinson's Disease

  2019cites this paper
• Significantly different contact patterns between Aβ40 and Aβ42 monomers involving the N‐terminal region

  2019cites this paper
• A short perspective on the long road to effective treatments for Alzheimer's disease

  2019cites this paper
• Important advances in Alzheimer’s disease from the use of induced pluripotent stem cells

  2019cites this paper
• A Close Look at BACE1 Inhibitors for Alzheimer’s Disease Treatment

  2019cites this paper
• Processing of Mutant β-Amyloid Precursor Protein and the Clinicopathological Features of Familial Alzheimer’s Disease

  2019cites this paper
• The vexing complexity of the amyloidogenic pathway

  2019cites this paper
• Therapeutic Strategies Targeting Amyloid-β in Alzheimer's Disease.

  2019cites this paper
• Protective Variants in Alzheimer’s Disease

  2019cites this paper
• New molecular approaches to Alzheimer's disease.

  2019cites this paper
• The Y682ENPTY687 motif of APP: Progress and insights toward a targeted therapy for Alzheimer's disease patients.

  2019cites this paper
• Modeling Alzheimer’s disease with iPSC-derived brain cells

  2019cites this paper
• A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.

  2019cites this paper
• AAV mediated delivery of a novel anti-BACE1 VHH reduces Abeta in an Alzheimer’s disease mouse model

  2019cites this paper
• Modeling of Alzheimer’s Disease and Outlooks for its Therapy Using Induced Pluripotent Stem Cells

  2019cites this paper
• BACE1 partial deletion induces synaptic plasticity deficit in adult mice

  2019cites this paper
• Investigation of neuronal activity in a murine model of Alzheimer’s disease using in vivo two-photon calcium imaging

  2019cites this paper
• Consequences of Pharmacological BACE Inhibition on Synaptic Structure and Function.

  2018cites this paper
• Fluorescence imaging of the interaction of amyloid beta 40 peptides with live cells and model membrane.

  2018cites this paper
• The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade

  2018cites this paper
• The Role of Genetics in Advancing Precision Medicine for Alzheimer’s Disease—A Narrative Review

  2018influential citation
• Increased Foxo3a nuclear translocation and activity is an early neuronal response to β  ‐ secretase ‐ mediated processing of the Amyloid ‐β‐ Protein Precursor Protein: Utility of an A β PP ‐ GAL4 reporter

  2018influential citation
• Modulation of γ- and β-Secretases as Early Prevention Against Alzheimer's Disease.

  2018cites this paper
• Confirmation and Characterization of a Functional APP/GAP-43 Protein Interaction

  2018cites this paper
• Génération de cellules souches pluripotentes induites de patients Alzheimer et production d'un modèle de culture en trois dimensions de neurones pour les recherches diagnostiques et thérapeutiques de la maladie d’Alzheimer

  2018influential citation
• Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology

  2018cites this paper
• Implication des systèmes de dégradation cellulaire, de la protéine VCP et de nouvelles molécules sur le métabolisme de l’APP : aspects fondamentaux et appliqués à la maladie d’Alzheimer

  2018cites this paper
• Modulation in the conformational and stability attributes of the Alzheimer’s disease associated amyloid-beta mutants and their favorable stabilization by curcumin: molecular dynamics simulation analysis

  2018cites this paper
• Differential effect of amyloid beta peptides on mitochondrial axonal trafficking depends on their state of aggregation and binding to the plasma membrane

  2018cites this paper
• The genetic landscape of Alzheimer disease.

  2018cites this paper
• Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5′-untranslated region: Implications in Alzheimer’s disease

  2018cites this paper
• Role of Amyloid Precursor Protein (APP) and Its Derivatives in the Biology and Cell Fate Specification of Neural Stem Cells

  2018cites this paper
• mediated processing of the Amyloid ‐ β ‐ Protein Precursor Protein : Utility of an A β PP ‐ GAL 4 reporter assay

  2018influential citation
• mediated processing of the Amyloid ‐ β ‐ Protein Precursor Protein : Utility of an A β PP ‐ GAL 4 reporter assay

  2018influential citation
• mediated processing of the Amyloid ‐ β ‐ Protein Precursor Protein : Utility of an A β PP ‐ GAL 4 reporter assay

  2018influential citation
• Aβ propagation and strains: Implications for the phenotypic diversity in Alzheimer's disease.

  2018cites this paper
• Packing Density of the Amyloid Precursor Protein in the Cell Membrane.

  2018cites this paper
• Serotonin, β‐amyloid, and cognition in Parkinson disease

  2018cites this paper
• Hydrophobic Modification of Carboxyl-Terminated Polyamidoamine Dendrimer Surface Creates a Potent Inhibitor of Amyloid-β Fibrillation.

  2018cites this paper
• A phenotypic approach to the discovery of compounds that promote non-amyloidogenic processing of the amyloid precursor protein: Toward a new profile of indirect β-secretase inhibitors.

  2018cites this paper
• Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer's Disease.

  2017cites this paper
• Coarse‐grained and All‐atom Simulations towards the Early and Late Steps of Amyloid Fibril Formation

  2017cites this paper